Lv6
1946 积分 2023-03-09 加入
Cellular and signalling mechanisms that regulate the blood–brain barrier
12天前
已完结
CD98hc-targeted antibody shuttles for central nervous system delivery with broad cross-species reactivity
1个月前
已完结
In vitro blood-brain barrier models for the study of brain shuttle peptide transport
2个月前
已完结
In vitro blood-brain barrier models for the study of brain shuttle peptide transport
2个月前
已关闭
Toward non-invasive CNS delivery: The emergence of brain shuttle peptides
2个月前
已完结
Toward non-invasive CNS delivery: The emergence of brain shuttle peptides
2个月前
已关闭
SKY59, A Novel Recycling Antibody for Complement-mediated Diseases
2个月前
已完结
Pharmacokinetic characterization and exposure–response relationship of crovalimab in the COMMODORE 1, 2 and 3 and COMPOSER trials of patients with paroxysmal nocturnal haemoglobinuria
2个月前
已完结
Safety of Crovalimab Versus Eculizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria (PNH): Pooled Results From the Phase 3 COMMODORE Studies
2个月前
已完结
Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long‐term results from the phase I/II COMPOSER trial
2个月前
已完结
皖公网安备34019202002308
